BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12427913)

  • 1. Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment.
    Kalfakis N; Panas M; Karadima G; Floroskufi P; Kokolakis N; Vassilopoulos D
    Neurology; 2002 Nov; 59(9):1470-1. PubMed ID: 12427913
    [No Abstract]   [Full Text] [Related]  

  • 2. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
    Olek MJ; Bordeaux B; Leshner RT
    J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.
    Naumann R; Mohm J; Reuner U; Kroschinsky F; Rautenstrauss B; Ehninger G
    Br J Haematol; 2001 Nov; 115(2):323-5. PubMed ID: 11703329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.
    Mercuri E; Poulton J; Buck J; Broadbent V; Bamford M; Jungbluth H; Manzur AY; Muntoni F
    Arch Dis Child; 1999 Nov; 81(5):442-3. PubMed ID: 10519723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease.
    Aghajan Y; Yoon JM; Crawford JR
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28438772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charcot-Marie-Tooth disease and vincristine.
    Orejana-García AM; Pascual-Huerta J; Pérez-Melero A
    J Am Podiatr Med Assoc; 2003; 93(3):229-33. PubMed ID: 12756314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD; Smith AA; Odom LF
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract]   [Full Text] [Related]  

  • 8. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
    Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary neuropathy with liability to pressure palsies in childhood].
    de las Cuevas I; Arteaga R; García A; Herranz JL
    Rev Neurol; 2000 Jul 1-15; 31(1):38-41. PubMed ID: 10948581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vincristine-induced fatal neuropathy in non-Hodgkin's lymphoma.
    Tarlaci S
    Neurotoxicology; 2008 Jul; 29(4):748-9. PubMed ID: 18754106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.
    Neumann Y; Toren A; Rechavi G; Seifried B; Shoham NG; Mandel M; Kenet G; Sharon N; Sadeh M; Navon R
    Med Pediatr Oncol; 1996 Apr; 26(4):280-3. PubMed ID: 8600343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.
    Graf WD; Chance PF; Lensch MW; Eng LJ; Lipe HP; Bird TD
    Cancer; 1996 Apr; 77(7):1356-62. PubMed ID: 8608515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome?
    Bahl A; Chakrabarty B; Gulati S; Raju KN; Raja A; Bakhshi S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1234-5. PubMed ID: 20544812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease.
    Weimer LH; Podwall D
    J Neurol Sci; 2006 Mar; 242(1-2):47-54. PubMed ID: 16386273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated abducens nerve palsy induced by vincristine therapy.
    Toker E; Yenice O; Oğüt MS
    J AAPOS; 2004 Feb; 8(1):69-71. PubMed ID: 14970804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary neuropathy with liability to pressure palsies: a patient's point mutation in a mouse model.
    Chance PF; Dyck PJ
    Neurology; 1998 Sep; 51(3):664-5. PubMed ID: 9748005
    [No Abstract]   [Full Text] [Related]  

  • 18. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A.
    Young P; Stögbauer F; Wiebusch H; Löfgren A; Timmerman V; Van Broeckhoven C; Ringelstein EB; Assmann G; Funke H
    Neurology; 1998 Mar; 50(3):760-3. PubMed ID: 9521270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vincristine-induced urinary bladder paralysis.
    El Hayek M; Trad O; Jamil A
    J Pediatr Hematol Oncol; 2005 May; 27(5):286-7. PubMed ID: 15891567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary neuropathy with pressure palsies].
    Gjerde IO; Aarskog N; Vedeler C
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):426-8. PubMed ID: 11255855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.